RxDoctor Payments Data

Gehan Morel

Primary Care · Passaic, NJNPI 1982156832

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Neos Therapeutics, LP at 24.3% of the total. Reporting peaked in 2022 at $1,118 and has fallen 95.7% since, to $48 in 2025.

$3,205in general payments, 2019–2025

Across 219 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neos Therapeutics, LP$778
  • Supernus Pharmaceuticals, Inc.$610
  • AbbVie$280
  • Novo Nordisk$250
  • Amgen$229
  • Novartis$117
  • plus $941 from 21 others

What the payments were for

  • Food & beverage$3,205100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,205 in reported general payments places this provider in the 85th percentile of 330 primary care providers in New Jersey.

See all primary care providers in New Jersey

Other primary care in Passaic

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →